Publication | Closed Access

Impact of mother donor, peripheral blood stem cells and measurable residual disease on outcomes after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in children with acute leukaemia

Acute LeukaemiaTransplantationMarrow TransplantationBone Marrow FailurePediatric HematologyStem Cell TransplantationHematologyPediatricsBlood TransplantationMeasurable Residual DiseaseMedicineCell TransplantationMother Donor